These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 29565400)
21. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità. Ingrosso L; Rezza G; Pocchiari M; Garaci E Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551 [No Abstract] [Full Text] [Related]
22. How academic labs can approach the drug discovery process as a way to synergize with big pharma. Loregian A; Palù G Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493 [TBL] [Abstract][Full Text] [Related]
23. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia]. Iida K; Yano T; Ikemori M; Ishida T; Nishimura N Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438 [TBL] [Abstract][Full Text] [Related]
24. Europe bets on drug discovery. Baker M Nature; 2013 Feb; 494(7435):20. PubMed ID: 23393658 [No Abstract] [Full Text] [Related]
25. Bringing together the academic drug discovery community. Slusher BS; Conn PJ; Frye S; Glicksman M; Arkin M Nat Rev Drug Discov; 2013 Nov; 12(11):811-2. PubMed ID: 24172316 [TBL] [Abstract][Full Text] [Related]
26. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. Hedner T; Gatenbeck L Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257 [No Abstract] [Full Text] [Related]
27. The art of the alliance. Menzel GE; Xanthopoulos KG Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275 [No Abstract] [Full Text] [Related]
28. Traditional drug-discovery model ripe for reform. Cressey D Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796 [No Abstract] [Full Text] [Related]
30. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]
31. European lead factory opens for business. Mullard A Nat Rev Drug Discov; 2013 Mar; 12(3):173-5. PubMed ID: 23449292 [No Abstract] [Full Text] [Related]
33. Industry is more alarmed about reproducibility than academia. Bespalov A; Barnett AG; Begley CG Nature; 2018 Nov; 563(7733):626. PubMed ID: 30487623 [No Abstract] [Full Text] [Related]
34. Tuberculosis drug discovery needs public-private consortia. Cole ST Drug Discov Today; 2017 Mar; 22(3):477-478. PubMed ID: 27717851 [No Abstract] [Full Text] [Related]
35. Comment: Drawing a new bottom line. Sunami A Nature; 2017 Mar; 543(7646):S22. PubMed ID: 28328908 [No Abstract] [Full Text] [Related]
36. Drug discovery and development for neglected diseases: the DNDi model. Chatelain E; Ioset JR Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487 [TBL] [Abstract][Full Text] [Related]